Related Experiment Video
Updated: Feb 17, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Pathogenic peculiarities of disseminated intravascular coagulation of various ethiology]
Insights
Disseminated intravascular coagulation (DIC) is a severe condition with multiple causes and varied mechanisms. Understanding the specific hemostasis disorder in DIC is key to effective prevention, diagnosis, and treatment.
Area of Science:
- Hematology
- Pathophysiology
- Critical Care Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a life-threatening syndrome characterized by widespread activation of coagulation, leading to both thrombosis and hemorrhage.
- It is a polyethiological condition, with over 150 described diseases capable of triggering its development.
- The diverse causes of DIC result in varied underlying mechanisms and clinical presentations, complicating management.
Purpose of the Study:
- To elucidate the diverse etiologies and pathomechanisms of disseminated intravascular coagulation (DIC).
- To highlight the variability in the initial stages and clinical manifestations of DIC.
- To emphasize the importance of identifying the predominant hemostatic derangement for optimal patient management.
Main Methods:
- Review of existing literature on the pathophysiology of DIC.
- Analysis of triggering mechanisms including blood cell activation, coagulation pathway activation, and fibrinolytic system involvement.
- Categorization of DIC based on prevailing coagulation or fibrinolysis activity.
Main Results:
- DIC presents with both thrombotic (clottage) and hemorrhagic (bleeding) manifestations, stemming from microvascular thrombosis and consumption of coagulation factors.
- Key initiating mechanisms include activation of blood elements, intrinsic/extrinsic coagulation pathways, anticoagulant deficiency, and excessive fibrinolysis.
- DIC can manifest with predominant coagulation, fibrinolysis, or a balanced activation, influencing disease progression and clinical picture.
Conclusions:
- The varied etiology and complex pathophysiology of DIC necessitate a nuanced approach to diagnosis and treatment.
- Recognizing the specific hemostatic imbalance (coagulation vs. fibrinolysis) in a potentially DIC-inducing disease is crucial.
- Tailoring prevention, diagnostic, and therapeutic strategies based on the predominant pathophysiological derangement can improve outcomes in DIC.
Abstract:
DIC is a severe complication, often resulting in multi-organ failure and fatal outcome. As any syndrome, it is polyethiologic, while a big number of its causes logically leads to various mechanisms of its forming. Main manifestations of the disseminated intravascular blood coagulation syndrome are clottage and haemorrhage. A result of a massive clottage in microcirculatory bed of internal organs is development of dystrophic changes in them and organ failure. Haemorrhage in its turn, results in decreased volume of circulating blood, arterial hypotension and hemic hypoxia, in most severe cases leading to the fatal outcome. Although, development mechanisms and manifestation degree of the disorder mentioned above are not always the same. As the syndrome may result from a great number of causes (currently, over 150 diseases have been described with which it can develop), namely its initial stages are different to the greatest extent. Main triggering mechanisms of the DIC may be: blood formed element activation and increased process of their microvesiculation, activation of coagulative hemostasis in intrinsic and extrinsic pathways, lack of anticoagulants and excessive activity of fibrinolytic system. Various ethiologic factors (sepsis, obstetrical pathology, leucosis and other malignant tumours, traumas, etc) have different effect on function of hemostasis system components. Depending on the degree of the above mentioned disorders mechanisms manifestation, the DIC may develop with prevailing coagulation, with prevailing fibrinolysis or with their balanced activation. Clinical manifestations of these DIC forms, as well as duration and manifestation degree of its stages (hypercoagulation, coagulopathy of consumption with compensatory activation of fibrinolysis, defibrination of the blood and excessive activation of fibrinolysis) will be different as well. Consequently, knowing the prevailing disorder in hemostasis system during a disease that is potentially dangerous in terms of the DIC development offers to find optimal methods of its prevention, diagnosing and treatment.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis I: Introduction
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation